Jan 10, 2022 / 12:30PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Bristol-Myers to again kick off the JPMorgan Healthcare Conference this year. From the company, we have Giovanni Caforio, Chairman and CEO.
And before I turn it over to Giovanni, I just wanted to remind people that if you want to ask a question, feel free to use the Ask a Question feature on the website, and we'll work those into the Q&A post the presentation.
With that, Giovanni, Happy New Year, and thanks again for joining us. Looking forward to the presentation today.
Giovanni Caforio - Bristol-Myers Squibb Company - Chairman of the Board & CEO
Thank you, Chris. Thank you, and good morning, everyone. It's great to be with all of you this morning.
On Slide 2, you can see our legal disclosures. But let me start right away on Slide 3. Bristol Myers Squibb today is a company well positioned to drive growth through the decade. And we have multiple
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot